From January 1, 2023 to March 31, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 11,937,264 shares, representing 1.04% for CNY 170.04 million under the buyback announced on May 6, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.56 CNY | +1.19% | +0.52% | -10.44% |
23/05 | Aodong Medicine Industry's Unit Gets Certificates for 10 Traditional Chinese Medicines | MT |
20/05 | Jilin Aodong Pharmaceutical Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.44% | 220.52Cr | |
+56.86% | 82TCr | |
+43.90% | 64TCr | |
-6.57% | 35TCr | |
+17.32% | 31TCr | |
+9.94% | 30TCr | |
+16.08% | 24TCr | |
+2.29% | 22TCr | |
+13.96% | 22TCr | |
+7.98% | 17TCr |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on May 6, 2022.